There were no significant differences between the study regimens by the outcome criteria evaluated. Septic-related mortality occurred in 18 (19%) patients, and two (2%) patients had unrelated deaths. Twenty-five patients (27%) subsequently developed unsatisfactory courses, but 48 (52%) patients remained well through the 30-day period. Initial satisfactory clinical responses were obtained in 59 (63%) patients. CHQ Paediatric Aminoglycoside therapeutic drug monitoring guidelines. Adult Statewide Guidelines on Aminoglycoside Usage and the. The following guidelines should be read in conjunction with the. abscessus, an often difficult to treat organism. Amikacin is a core drug in the treatment of. Study antibiotics were changed for bacteriologic reasons in 11 patients taking clindamycin-gentamicin and 12 patients taking chloramphenicol-gentamicin (25% of the total), and two patients in the clindamycin-gentamicin group had a minor adverse reaction. tobramycin is the aminoglycoside of choic e. The duration of antibiotic treatment averaged 8½ days, and the average length of postoperative hospitalization was 29 days. Synergy between rifampin and other agents has been demonstrable for a number of species in. with Infective Endocarditis due to gram-positive organisms (synergy. Malnutrition, age over 65 years, shock, alcoholism, gastrointestinal tract bleeding, steroid administration, diabetes, obesity, and organ malfunction were present with equal frequencies in each group. MAC strains are inhibited in vitro by 4 to 16 g/mL of rifampin. EIDA is the preferred method for dosing aminoglycosides for gram-negative infections. The study compared clindamycin-gentamicin and chloramphenicol-gentamicin for treatment of carefully stratified patient groups.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |